Drug Abstinence Self-Efficacy Scale (DASES) : psychometric properties of the Farsi version by Khazaee-Pool, Maryam et al.
RESEARCH Open Access
Drug Abstinence Self-Efficacy Scale (DASES):
psychometric properties of the Farsi version
Maryam Khazaee-Pool1,2* , Seyed Abolhassan Naghibi1,2*, Tahereh Pashaei3*, Mosharafeh Chaleshgar-Kordasiabi1,2,
Mahbobeh Daneshnia4 and Koen Ponnet5
Abstract
Background: Research has demonstrated that therapeutic interventions based on the self-efficacy theory produce
positive outcomes for people who exhibit addictive behaviors, such as alcohol and drug use. Several questionnaires
based on self-efficacy theory have been developed to evaluate the extent to which intervention programs can
modify behavior. The present study describes the psychometric properties of the Farsi version of the Drug
Abstinence Self-Efficacy Scale (DASES).
Design and methods: The forward–backward approach was employed to translate the DASES from English into
Farsi. A cross-sectional study was conducted, and the psychometric properties of the Farsi version of the DASES
were measured. Using a cluster sampling method, 400 male people who use drugs aged 20 years or older were
selected from 10 addiction treatment clinics in Mazandaran, Iran. The internal consistency and test–retest methods
were used to measure the reliability of the DASES. Face and content validity were measured, and the construct
validity of the DASES was assessed through both exploratory factor analysis (EFA) and confirmatory factor analysis
(CFA). The data were analyzed using SPSS and AMOS.
Results: The results of the EFA indicated a four-factor solution for the DASES that accounted for 64.72% of the
observed variance. The results obtained from the CFA demonstrated that the data fitted the model: the relative chi
square (× 2/df) equaled 1.99 (p < 0.001), and the root mean square error of approximation equaled 0.071 (90% CI =
0.059–0.082). All the comparative indices of the model were equal to or greater than 0.90 (0.91, 0.93, 0.94, 0.93, and
0.90, respectively). The Cronbach’s alpha ranged from 0.90 to 0.93, proving a satisfactory reliability. Additionally, the
intraclass correlation coefficient ranged from 0.75 to 0.98, which is an acceptable result.
Conclusions: This study’s results show that the Iranian version of the DASES has good psychometric properties and
is appropriate for assessing substance use behaviors among Iranian addicted persons.
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Background
Substance use disorder, a chronic, persistent disease as-
sociated with personal, familial, and social dysfunctions,
is one of the world’s more challenging health care prob-
lems [1–3]. The prevalence of substance use has been
fixed at around 0.5% of the global population over the
past decade, but it differs by area and type of drug used.
East and Southeast Asia are among the main centers for
the production and transportation of illegal drugs [4].
Iran shares a border with Afghanistan, a major manufac-
turer of narcotics, which facilitates the importation of
illicit drugs to Iran [3, 5]. As in other Islamic countries,
substance use is forbidden in Iran based on Islamic law,
customs, and social values [6]. Despite this, Iran ranks
high in opium use; about 1.8–3.3 million persons use
drugs annually [3], and drug and alcohol disorders make
up about 2% of the total disease burden [7]. As Iran is
recognized as having among the highest rates of drug
use for heroin, cannabis, and methamphetamine, it is
not surprising that drinking alcohol and using drugs
comprise almost 2% of the country’s disease burden [8].
Substance use prevention, particularly primary preven-
tion, is the most economical and potentially effective
solution to this problem [9], but clear indications of the
characteristics of substance use disorder are a prerequis-
ite for substance use prevention. Successful methods of
ending drug use are often based on behavioral change
models and theories, and two cognitive-behavioral theor-
ies have been suggested that may explain the relapse
process and that offer important suggestions for design-
ing effective management approaches [10, 11]. Albert
Bandura developed the self-efficacy theory based on
social cognitive theory, according to which individuals
can influence their setting and environment rather than
merely reacting to them. Self-efficacy aligns with this as
it relies on individuals’ belief in their capacity to execute
the behaviors needed to produce specific results [12].
According to the theory, if individuals do not believe
they have the capacity to implement the behavior needed
to reach the desired goal, they will put forth minimal ef-
fort or not engage in that behavior. Self-efficacy beliefs
are also believed to vary depending on the domain of
functioning and the circumstances of the behavior’s
occurrence [10, 12].
The theory suggests that self-efficacy can alter behav-
ior through the recognition of background signs and
through encouragement to achieve a specific result.
Effective interventions to decrease drug use or other
addictive behaviors are supposed to strengthen efficacy
beliefs related to a person’s ability to reduce the desire
to take part in such behaviors [12]. Self-efficacy is a key
factor in treating substance use as individuals must be
confident of their ability to stop using drugs. Without
self-efficacy, treatment can be challenging. In fact,
people who use drugs may believe that they cannot stop
using substances.
In the context of substance use, self-efficacy can influ-
ence a people’s ability to withdraw from drug use when
they are close to other persons who consume drugs, are
pressured by others to use, or are in specific settings
[13]. It is often hard for people who use drugs to resist
the temptation to use, and strong self-efficacy beliefs
may help them resist [14].
Based on social cognitive theory, many instruments
have been developed to assess the degree to which inter-
ventions can change personal behavior. One such scale
in substance abstinence, based on the self-efficacy struc-
ture of Bandura’s social cognitive theory, is the Drug
Abstinence Self-Efficacy Scale (DASES) [15]. DASES is a
20-item self-report survey that measures confidence in
one’s ability to abstain from using drugs in specific situa-
tions. The test results can help in assessing whether an
individual is ready for drug treatment and in determin-
ing the right mode of treatment. High scores on the
DASES indicate that individuals have more confidence
in their ability to abstain from drugs. Conversely, low
scores indicate that they do not believe they can resist
the temptation to use drugs [15]. This information can
help medical professionals determine the treatment path
and aid therapists in improving self-efficacy. DiClemente
et al. (1994) developed the Alcohol Abstinence Self-
Efficacy Scale (AASES), which was adapted by Hiller and
colleagues (2000) [15] into the DASES [16]. The DASES
has been validated in other countries [15], but no study
has validated it in Iran.
As cultural and linguistic factors may impact how re-
spondents complete the original version of the DASES,
it is important to reevaluate the validity and reliability of
DASES in different cultures, such as that of Iran. There-
fore, the present study measures the psychometric prop-
erties of the Iranian version of the DASES to support
abstinence in Iranian drug-addicted persons.
Methods
Sample and data collection
To evaluate the psychometric properties of the DASES
among drug-addicted people aged 20 years and older, a
cross-sectional study was conducted in Mazandaran,
Iran, in November–December 2019. Twelve addiction
treatment clinics in Mazandaran participated in the
study. A cluster sampling method was used where each
cluster contained the same number of respondents. First,
Mazandaran was divided into three regions (east, west,
and central), and all the addiction treatment clinics in
them were identified. Next, four clinics were randomly
selected from each region. Patients who were referred to
the clinics were asked whether they were willing to
participate in the study. Only patients over 20 years’ old
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who could read and write in Farsi were eligible to
participate.
After the first author conducted a short interview and
provided information on the study’s process, the patients
who agreed to participate completed the DASES. They
had been assured that their responses were anonymous
and confidential and that they could terminate their par-
ticipation at any time, whereupon they provided written
consent. The participants’ demographic characteristics,
including age, employment status, educational level,
marital status, and age when starting drug use, were also
collected (see Table 1). The participants answered a
paper-and-pencil questionnaire, which took 20–25 min
to complete.
Measurement
The drug abstinence self-efficacy scale (DASES)
The DASES [15] is a modified version of the AASES,
which was devised in 1994 by DiClemente et al. [16].
Due to the relative lack of tools to assess self-efficacy in
drug abstinence, Hiller et al. (2000) tested the AASES
questionnaire on a sample of people who use drugs and
estimated its psychometric properties. The DASES
assesses an individual’s efficacy (e.g., confidence) in
abstaining from drugs in 20 typical drug-taking situations.
It has been confirmed as an effective self-measurement
scale that can lead to improved motivation for changing
behavior [17, 18]. Individuals are asked to estimate their
current efficacy in abstaining from drugs. The situations
embrace four subscales and are rated on a 5-point Likert
scale ranging from not at all (0) to extremely (4), with the
total score ranging from 0 to 80 and higher scores indicat-
ing greater self-efficacy in abstaining from drugs [15].
These scales may also be used to evaluate personal treat-
ment, the progress of drug treatment, relapse potential,
and post-treatment functioning. Hiller et al. found a
Cronbach’s alpha of 0.90 for the 20-item DASES and
Cronbach’s alphas of 0.92, 0.92, 0.89, and 0.87 for the
subscales (Negative Affect, Social Pressure, Cravings
and Urges, and Physical and Other Concerns about
Using Drugs, respectively) [15].
Translation procedures
The authors received permission from the developers of
DASES to translate it from English into Farsi by applying
a forward–backward approach [19]. First, two independ-
ent, professional, native Farsi translators translated the
DASES into Farsi. Next, those two versions were com-
pared by one of the authors and both the translators and
aggregated into a single version of the DASES. In the
backward phase, two other persons who spoke fluent
Farsi and English translated the Farsi version of the
DASES back into English, and a provisional English
version of the DASES was made. The accuracy of the
back-translated DASES was then evaluated. To measure
the content validity, a panel of experts (an epidemiolo-
gist, a health promotion expert, and an expert in drug
control) compared the provisional English version of the
DASES with the original instrument. The final Iranian
version of the DASES was then produced [20].
Psychometric testing
To examine the psychometric properties of the Iranian
version of the DASES, we assessed its content, face, and
construct validity as well as its reliability and stability.
Content validity
Both qualitative and quantitative approaches were used
to assess the content validity. In the qualitative phase, a
panel of experts, including health promotion experts,
epidemiologists, and specialists in drug-use control,
measured the content validity of the DASES, evaluating
its phrasing, grammar, wording, item allocation, and
scaling. In the quantitative phase, the content validity
index (CVI) and content validity ratio (CVR) of the
DASES were assessed. The CVI was assessed by asking
the experts to rate each item according to its simplicity,
relevance, and clarity [21] on a scale from 1 = not rele-
vant, simple, or clear to 4 = very relevant, simple, and
clear. The CVI was measured as the proportion of items
on the questionnaire that achieved a rating of 3 or 4 [22, 23].
The essentiality of each item in the questionnaire was






sample (n = 35)
Number (%) Number (%) Number (%)
Age (years)
20–29 39 (19.5) 47 (23.5) 16 (45.7)
30–39 86 (43) 77 (38.5) 9 (25.7)
≥ 40 75 (37.5) 76 (38) 10 (28.6)
Employment status
Unemployed 68 (34) 61 (30.5) 19 (54.3)
Part time job 72 (36) 84 (42) 7 (20)
Full time job 60 (30) 55 (27.5) 9 (25.7)
Educational Level
Primary 47 (23.5) 43 (21.5) 9 (25.7)
Secondary 134 (67) 129 (64.5) 14 (40)
Higher 19 (9.5) 28 (14) 12 (34.3)
Marital status
Single 64 (32) 68 (34) 10 (28.6)
Married 81 (40.5) 95 (47.5) 14 (48.5)
Divorced / widowed 55 (27.5) 37 (18.5) 8 (22.9)
Basic sample demographics broken down by EFA, CFA, and
Test–retest samples
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evaluated by the CVR. To measure the CVR, the specialists
rated each item as 1 = essential, 2 = useful but not essential,
or 3 = not essential. Afterward, according to the Lawshe table,
items with a CVR score of 0.62 or greater were determined
to be acceptable and were maintained [23].
Face validity
Both a qualitative and a quantitative approach were used
to measure face validity. A sample of addicted males
(n = 10) was asked to assess each item of the Iranian ver-
sion of the DASES, and indicate whether they experi-
enced difficulty or confusion in answering it. Afterward,
the impact score (importance × frequency) was measured
to determine the percentage of addicted persons who
recognized an item as important or quite important on a
5-point Likert instrument. An item was determined to
be suitable if it had an impact score of 1.5 or higher
(which equals a mean rate of 50% and a mean import-
ance of 3 out of 5) [24].
Construct validity
Exploratory factor analysis
An EFA was performed to find the main factors of the
DASES. The sample size was assessed a priori and was
estimated according to the number of items in the
instrument multiplied by 10 (10 × 20 = 200) [25]. The
participants were recruited from the 12 clinics. In a
section below, we describe the characteristics of the
sample. A principal component analysis with varimax
rotation was applied to extract the main factors. Factor
loadings of ≥ 0.40 were considered acceptable [26].
Confirmatory factor analysis
A CFA was performed to measure the coherence be-
tween the model and the data. Considering the possible
attrition related to test–retest analysis, we planned to
recruit a separate sample of addicted persons from the
12 clinics in Mazandaran. Assigning 10 individuals to
each item, a sample size of 200 was estimated [27]. To
assess the model fit, the relative chi square, comparative
fit index (CFI), goodness of fit index (GFI), root mean
square error of approximation (RMSEA), standardized
root mean square residual (SRMR), normed fit index
(NFI), and non-normed fit index (NNFI) were measured
[28, 29]. CFI, GFI, NNFI, and NFI values range from 0
to 1, but values equal to or greater than 0.80 are gener-
ally considered satisfactory model fits. An RMSEA value
between 0.08 and 0.10 indicates a mediocre fit, and a
value lower than 0.08 indicates a good fit. Values of less
than 0.05 indicate a good fit for the SRMR while values
between 0.05 and 0.08 and between 0.08 and 0.10 repre-
sent a close fit and a satisfactory fit, respectively [30].
Internal consistency and homogeneity
The internal consistency was assessed using the
Cronbach’s alpha coefficient to measure the reliability of
the DASES. Alpha values equal to or greater than 0.70
were considered acceptable [31]. Moreover, the item-
total correlations and mean inter-item correlations were
contained within the analysis. Westen (2005) advises
that it is necessarily to assess the inter-item correlation
as a criterion for internal consistency and suggests that
all-person inter-item correlations should be 0.15 or
greater [32]. One-dimensionality can be confirmed only
if the all-person inter-item correlations are grouped
approximately near the mean inter-item correlation. The
corrected item-total correlation is the correlation of the
item chosen with the accumulated score for all the other
items [33]. Thus, the corrected item-total correlation
was applied.
Stability
Additionally, the intraclass correlation coefficient (ICC)
was assessed to evaluate the stability of the DASES,
which was re-administered to 30 addicted men two
weeks after the first completion. ICC values equal to or
greater than 0.40 are considered satisfactory (r values
between 0.81 and 1.0 are excellent, those between 0.61
and 0.80 are very good, those between 0.41 and 0.60 are
good, those between 0.21 and 0.40 are fair, and those
between 0.0 and 0.20 are poor) [31]. The analyses were
performed using the statistical program SPSS for Windows
version 24.0 and Amos 24.0.
Results
Demographic characteristics of the participants
In this study, 400 addicted men aged 20 years or older
completed the DASES (200 participants for EFA and 200
for CFA). The largest group in the sample comprised
men aged 30–39 years (40.75%). Regarding employment
status, 32.25% (129 participants) were unemployed, 39%
(156 participants) had part-time jobs, and 28.75% (115
participants) worked full time. Most of the participants
(65.75%) had a secondary level of education, and 44% of
the sample were married. Table 1 provides an overview
of the descriptive characteristics of sample 1 (EFA),
sample 2 (CFA), and sample 3 (test–retest).
Content validity
The translated DASES was arbitrated for relevance and
for the phrasing of the items by the expert panel members,
who could suggest practical phrasing enhancements for
each item. Subsequent to this, the revision of the Farsi
DASES was prepared and debated once more by the
expert panel until agreement was reached on the content.
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Construct validity
Exploratory factor analysis
An EFA was conducted on the 20 items of the DASES
(cutoff point: 0.50). The assessed Kaiser–Meyer–Olkin
coefficient was 0.792, with a p value of < 0.001, demon-
strating that the sample was large enough to provide a
satisfactory principal component analysis with varimax
rotation. In the 20-item scale, four factors revealed
eigenvalues greater than 1, explaining 64.72% of the
variance, and the scree plot also revealed a four-factor
solution (see Fig. 1).
The factor loadings of the 20 items were 0.40 or more,
ranging from 0.59 to 0.88. The factor loadings of each
item and the four dimensions are presented in Table 2.
All the items were loaded on their own dimensions.
Confirmatory factor analysis
We conducted a CFA on the 20-item DASES to assess
the fitness of the model obtained from the EFA, and co-
variance matrixes were analyzed. All the fit indices were
found to be appropriate. The relative chi square (χ2/df)
equaled 1.99 (p < 0.001). The RMSEA of the model was
0.071 (90% CI = 0.059–0.082), and the SRMR was 0.071.
All the comparative indices in the structural model, i.e.,
GFI, AGFI, CFI, NNFI, and NFI, were greater than 0.90
(0.91, 0.93, 0.94, 0.93, and 0.90, respectively). Even
though the model fit was acceptable and good, the
modification indices of the regression weights were ana-
lyzed to find the covariance among the four factors. The
model could not be improved, however, so no variations
were performed, and the model was accepted in its exist-
ing form. Figure 2 demonstrates the model.
Reliability
Internal consistency
The DASES completed by the 200 participants who use
drugs were used in the analyses. The instrument had an
overall Cronbach’s coefficient alpha of 0.96, and the
inter-item correlations ranged from 0.61 to 0.78. After-
ward, the alpha coefficient values for the items were
measured, which indicated that the internal consistency
level of the DASES was 0.96 and ranged from 0.81 for
the Negative Affect and Physical and Other Concerns
about Using Drugs sub-scales to 0.82 for the Social Pres-
sure and Cravings and Urges sub-scales, which is greater
than the acceptable threshold (Table 3).
Stability
Additionally, a test–retest analysis was conducted to
assess the stability of the DASES. The results found a
satisfactory threshold. The ICC ranged from 0.75 to 0.98
for the dimensions of the DASES, supporting the scale’s
stability. The results are presented in Table 3.
Fig. 1 Scree plot for determining the factors. Scree plot from the principal components analysis in the EFA sample
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Discussion
This study examined the factor validity, dimensionality,
and reliability of the DASES among Iranian people who
use drugs. Overall, the findings indicate that the psycho-
metric characteristics of the Farsi version of the DASES
are good. Consistent with other studies, we found a
four-factor structure [15, 16], indicating that improve-
ment in self-efficacy happens through several points and
consequently demonstrating the role of individual dis-
similarities, which urges further study within this popu-
lation. Furthermore, the development of theory-based
scales can serve as an important prerequisite for the as-
sessment of any educational program. Consequently, we
consider the results of the present study to be valuable
for clients who are part of a drug-control plan.
Overall, the study found satisfactory psychometric
properties for the DASES, with the CVI and CVR indi-
cating that its content validity was good. Furthermore,
the results of the EFA and CFA revealed a good struc-
ture for the DASES, with the EFA showing that the
four-factor structure of the DASES accounted for
64.72% of the total observed variance. The results of the
EFA were compatible with those achieved by the English
version of the DASES. This shows that the DASES is
useful for revealing various aspects of the health con-
cerns influenced by drug use. As expected, this study in-
dicated a four-factor solution for the Iranian version of
the DASES, including Negative Affect, Social Pressure,
Cravings and Urges, and Physical and Other Concerns
about Using Drugs subscales.
The CFA also examined whether coherence exists be-
tween the information and the theoretical structure. The
CFA revealed good fit indices for the existing model and
demonstrated the acceptable convergent validity of the
four subscales of the DASES (i.e., Negative Affect, Social
Pressure, Cravings and Urges, and Physical and Other
Concerns about Using Drugs). These findings related to
the CFA are consistent with the model from the original
instrument developed by Hiller et al. (2000) [15],
showing that the DASES is reliable when used by Farsi-
speaking addicted persons.
Additionally, acceptable levels of the Cronbach’s alpha
and the ICC were found, and the good stability and reli-
ability of the DASES were demonstrated. The internal
Table 2 Exploratory factory analysis of the DASES (n = 200)
Item
Negative Affect
Q6: When I am very worried .844 .045 .070 .006
Q3: When I am feeling depressed .844 .099 .004 -.101
Q14: When I feel like blowing up because of frustration .836 .012 .096 .041
Q16: When I sense everything is going wrong for me .834 -.012 .011 .036
Q18: When I am feeling angry inside .788 -.037 .012 -.070
Social Pressure
Q15: When I see others using drugs at a bar or a party .005 .882 -.013 .045
Q4: When I am on vacation and want to relax -.002 .876 .101 .145
Q8: When I am offered a drug in a social situation -.007 .832 -.016 .107
Q17: When people I used to drink with encourage me to use drugs -.027 .774 .119 .099
Q20: When I am excited or celebrating with others .106 .628 -.019 -.067
Physical and Other Concerns about Using Drugs
Q2: When I have a headache .004 -.029 .865 .032
Q13: When I am experiencing some physical pain or injury -.016 .060 .829 -.029
Q5: When I am concerned about someone .089 .157 .782 .006
Q9: When I dream about using a drug .048 .060 .781 .034
Q12: When I am physically tired .056 -.077 .710 -.009
Cravings and Urges
Q10: When I want to test my willpower over using drugs .034 .091 -.027 .834
Q7: When I have the urge to try just one drug use to see what happens .002 .010 .015 .812
Q11: When I am feeling a physical need or craving to use drugs -.030 .094 .028 .785
Q1: When I am in agony because of stopping or withdrawing from drug use -.003 .025 -.058 .750
Q19: When I experience an urge or impulse to take a drug that catches me unprepared -.065 .050 .059 .597
Factor loadings for four extracted principal components in the EFA sample following a varimax rotation
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consistency of the DASES, as evaluated by the Cron-
bach’s alpha, displayed a suitable reliability for the four
dimensions in accordance with the original study [15].
Moreover, after 35 male participants who use drugs were
tested over a two-week period, the test–retest reliability
coefficient of the DASES was a satisfactory 0.78. It is
generally held that assessments of repeatability for group
comparisons should be at least 0.70 [17, 34], so our
results clearly show that the DASES has appropriate sta-
bility in the short term; however, it has yet to be deter-
mined whether it is stable over the long term. Overall,
the findings indicate satisfactory psychometric properties
for the DASES.
The DASES provides an understanding of the pro-
cesses by which addicted persons attempt to modify
their addictive drug use behavior. The development of
Fig. 2 A four-factor model for the DASES obtained from CFA (n = 200). Schematic of the four-factor solution using the CFA showing loadings and
inter-factor correlations
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theory-based scales serves as an important prerequisite for
the assessment of any educational program. Consequently,
we consider the results from the present study to be valu-
able for clients who are taking part in a drug-control plan.
What is already known on this topic
Existing studies reveal that the incidence of substance
use is increasing worldwide [35], and increasing atten-
tion has been paid to the effect of self-efficacy as a
predictor and/or intermediary of remedy results in
numerous areas. In several studies of drug use remedies,
self-efficacy has appeared as a significant predictor of
the result or as an intermediary of the remedy’s influ-
ences [36]. Consequently, the DASES for this condition
is crucial to prevention inventions [15].
What this study adds
The Farsi version of the DASES may provide a valid
scale for Iranian patients with substance use difficulties.
It displays statistically satisfactory levels of validity and
reliability.
Limitations
Although the results of the current study reveal sev-
eral benefits, some limitations must be considered.
The first concerns the truthfulness of the clients’
responses due to the self-reported nature of the an-
swers. The generalizability and sample size constitute
other limitations. The sample was limited to a group
of 400 (both EFA and CFA) men who use drugs, and
it is uncertain whether we would attain the same
results if a larger sample of both male and female
participants who use drugs was employed. Conse-
quently, the present findings may not be able to
measure gender differences regarding the psychomet-
ric properties of the DASES. In future studies with a
larger group of both male and female people who use
drugs, researchers should consider measuring whether
motivations to cease drug use are similar between the
genders, whether gender affects acceptance of treat-
ment, and whether the current findings remain valid.
Furthermore, it would be interesting for future studies
with a larger sample to test whether the psychometric
properties of the instrument persist with alternative
measures of reliability and validity (e.g., test–retest
validity). Finally, the present study included only
addicted persons who were referred to clinics. Future
studies should also measure the psychometric properties
of the Iranian version of the DASES in Iranian addicted
persons who were referred to drop-in centers.









Q.1 76.67 106.494 .747 .954
Q.2 76.68 110.249 .617 .956
Q.3 76.70 109.928 .618 .956
Q.4 76.57 108.580 .704 .955
Q.5 76.69 108.130 .718 .955
Q.6 76.57 108.569 .671 .955
Q.7 76.58 107.099 .734 .954
Q.8 76.60 107.107 .729 .954
Q.9 76.64 108.002 .743 .954
Q.10 76.61 105.521 .783 .954
Q.11 76.61 104.938 .730 .954
Q.12 76.68 106.332 .733 .954
Q.13 76.67 106.794 .671 .955
Q.14 76.53 108.063 .709 .955
Q.15 76.56 107.570 .723 .954
Q.16 76.56 107.935 .713 .955
Q.17 76.57 107.434 .720 .954
Q.18 76.57 107.371 .702 .955
Q.19 76.59 105.472 .731 .954
Q.20 76.53 107.323 .699 .955
Item performance metrics for each of the DASES items
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Conclusion
The findings suggest that the Farsi version of the DASES
is a valid, reliable measure to assess drug use among
Iranian addicted men. The DASES is important because
it provides standardized information about substance
use self-efficacy behaviors. The use of a procedure and
method accepted in the scientific literature makes avail-
able the assessment of information garnered from di-
verse backgrounds. It is suggested that the DASES
should be further assessed in both dissimilar areas of
Iran and in different populations and cultures. When a
valid and reliable instrument is devised, it may be
applied to assess the consequences of intervention re-
search, and, as previously stated, it should be assessed
among dissimilar populations and backgrounds. The
scale that was assessed in the current study will contribute
positively to the progress of more effectual, evidence-
based anti–substance-use plans for the population. Fur-
thermore, the Farsi version of the DASES may help health
care workers to find and plan health strategies that are
useful and targeted to patients of particular statuses.
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